Clinical Trials Browser

Terminated × Glioblastoma × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT04963413 2025-08-06

RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.

Phase 1 Terminated

Glioblastoma

NCT03927222 2024-04-08

I-ATTAC

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

NCT01403285 2014-05-19

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Phase 1 Terminated

Glioblastoma